Latest Breaking News On - பேயர் மருந்துகள் பிரிவு - Page 1 : comparemela.com
Bayer Strengthens Drug Discovery Platform Through Acquisition of Vividion Therapeutics
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Bayer to acquire Vividion Therapeutics for novel drug discovery platform
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.
Article by Amanda Doyle
CUREVAC, which is developing an mRNA vaccine for Covid-19, will boost its manufacturing capacity via new agreements with Bayer and GSK.
CureVac already has an agreement with Bayer which will support the development and supply of CureVac’s mRNA candidate CVnCoV. Bayer has now announced that it is planning to manufacture 160m doses of CVnCoV in 2022.
Stefan Oelrich, President of Bayer’s Pharmaceuticals Division, said: “Although we have not previously produced vaccines, we hold strong expertise in the development of biotech products. Since the announcement of our alliance between Bayer and CureVac earlier this year, we have diligently assessed our ability to further contribute with end-to-end manufacturing.
Bayer transforms pharma business through breakthrough innovation in healthcare 13:48 | 14/01/2021
Bayer has made exciting progress in transforming its pharmaceutical business with breakthrough innovations in healthcare that will significantly help patients suffering from conditions that are currently still difficult to treat.
Bayer highlighted its focus on cell, gene, and oncology pipelines during its virtual Pharma Media Day in Germany
The information was stressed at its virtual Pharma Media Day titled âTransforming Healthcare. Transforming Bayerâ in Germany. The event highlighted Bayer s focus on the cell, gene, and oncology pipelines.
âThe biomedical and technological revolution that is transforming healthcare at an unprecedented pace is taking place now. Our company is at the forefront of the wave of innovation in cell and gene therapy as well as digital health,â said Stefan Oelrich, member of the board of management at Ba
Bayer s finerenone scores FDA priority review for chronic kidney disease
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.